OCUL
STRONGOCULAR THERAPEUTIX, INC
CIK: 0001393434
Sell
(70% confidence)
Last activity: 1 weeks ago
Financial Metrics
As of Dec 31, 2025 (10-K)
Revenue $1.99M
Total Cash $737.06M
Insider Roster (5 total, 5 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| Dugel Pravin See Remarks | 0 | 1 | -$235K | 3,157,960 shares $38.02M |
| Notman Donald Chief Operating Officer | 0 | 2 | -$101K | 377,802 shares $3.23M |
| Heier Jeffrey S. Chief Scientific Officer | 0 | 1 | -$42K | 245,940 shares $2.96M |
| Kaiser Peter Chief Development Officer | 0 | 1 | -$36K | 191,433 shares $2.30M |
| Nayak Sanjay Chief Strategy Officer | 0 | 1 | -$23K | 277,860 shares $3.35M |
Recent Transactions
SELL Notman Donald (Chief Operating Officer)
6,035 shares @ $8.54
$52K
Feb 4, 2026
Conviction: |
View SEC Filing →
SELL Notman Donald (Chief Operating Officer)
5,455 shares @ $9.14
$50K
Feb 2, 2026
Conviction: |
View SEC Filing →
SELL Dugel Pravin (See Remarks)
19,530 shares @ $12.04
$235K
Nov 24, 2025
Conviction: |
View SEC Filing →
SELL Heier Jeffrey S. (Chief Scientific Officer)
3,469 shares @ $12.04
$42K
Nov 24, 2025
Conviction: |
View SEC Filing →
SELL Kaiser Peter (Chief Development Officer)
3,007 shares @ $12.02
$36K
Nov 24, 2025
Conviction: |
View SEC Filing →
SELL Nayak Sanjay (Chief Strategy Officer)
1,878 shares @ $12.04
$23K
Nov 24, 2025
Conviction: |
View SEC Filing →
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.